
Media
Media
Our latest announcements
Hansa Biopharma to Participate in H.C. Wainwright 27th Annual Global Investment Conference
04/09/2025
Bulletin from the Extraordinary General Meeting in Hansa Biopharma AB (publ)
Regulatory press release
02/09/2025
Notice to Extraordinary General Meeting in Hansa Biopharma AB (publ)
Regulatory press release
07/08/2025
Hansa Biopharma announces supportive data from treatment with imlifidase prior to the administration of gene therapy for Duchenne muscular dystrophy
Regulatory press release
01/08/2025
Media articles
Insights
The Power of Hope: Redefining Treatment Decisions for Highly Sensitized Kidney Patients
07/08/2025
Collaboration across the continuum of care to improve equity for highly sensitized people in kidney transplantation
17/07/2024
A concerted collaboration to advance treatment options for people living with rare diseases
26/06/2024
Fueling the future: the role of biotech in advancing innovative science and delivering new medicines
02/05/2024